Skip to main content

Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.

Publication ,  Journal Article
Washam, JB; Herzog, CA; Beitelshees, AL; Cohen, MG; Henry, TD; Kapur, NK; Mega, JL; Menon, V; Page, RL; Newby, LK ...
Published in: Circulation
March 24, 2015

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 24, 2015

Volume

131

Issue

12

Start / End Page

1123 / 1149

Location

United States

Related Subject Headings

  • United States
  • Renal Insufficiency, Chronic
  • Humans
  • Cardiovascular System & Hematology
  • Cardiovascular Agents
  • American Heart Association
  • Acute Coronary Syndrome
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Washam, J. B., Herzog, C. A., Beitelshees, A. L., Cohen, M. G., Henry, T. D., Kapur, N. K., … American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics and Translational Biology, Council on the Kidney in Cardiovascular Disease, and Council on Quality of Care and Outcomes Research, . (2015). Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association. Circulation, 131(12), 1123–1149. https://doi.org/10.1161/CIR.0000000000000183
Washam, Jeffrey B., Charles A. Herzog, Amber L. Beitelshees, Mauricio G. Cohen, Timothy D. Henry, Navin K. Kapur, Jessica L. Mega, et al. “Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.Circulation 131, no. 12 (March 24, 2015): 1123–49. https://doi.org/10.1161/CIR.0000000000000183.
Washam JB, Herzog CA, Beitelshees AL, Cohen MG, Henry TD, Kapur NK, et al. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association. Circulation. 2015 Mar 24;131(12):1123–49.
Washam, Jeffrey B., et al. “Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.Circulation, vol. 131, no. 12, Mar. 2015, pp. 1123–49. Pubmed, doi:10.1161/CIR.0000000000000183.
Washam JB, Herzog CA, Beitelshees AL, Cohen MG, Henry TD, Kapur NK, Mega JL, Menon V, Page RL, Newby LK, American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics and Translational Biology, Council on the Kidney in Cardiovascular Disease, and Council on Quality of Care and Outcomes Research. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association. Circulation. 2015 Mar 24;131(12):1123–1149.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 24, 2015

Volume

131

Issue

12

Start / End Page

1123 / 1149

Location

United States

Related Subject Headings

  • United States
  • Renal Insufficiency, Chronic
  • Humans
  • Cardiovascular System & Hematology
  • Cardiovascular Agents
  • American Heart Association
  • Acute Coronary Syndrome
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology